<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>EVA Therapeutics, Inc. - Mobile-Friendly Interactive Business Deck</title>
    <style>
        body {
            margin: 0;
            padding: 0;
            font-family: Arial, sans-serif;
            background-color: #f0f0f0;
            color: #333;
            overflow-x: hidden;
        }
        #deck {
            position: relative;
            width: 100vw;
            height: 100vh;
            overflow: hidden;
        }
        .slide {
            position: absolute;
            top: 0;
            left: 0;
            width: 100%;
            height: 100%;
            padding: 20px;
            box-sizing: border-box;
            background: linear-gradient(135deg, #001f3f 0%, #0074D9 100%);
            color: white;
            display: none;
            opacity: 0;
            transition: opacity 0.5s ease-in-out;
            overflow-y: auto;
        }
        .slide.active {
            display: block;
            opacity: 1;
        }
        h1, h2 {
            color: #fff;
            text-align: center;
            margin-bottom: 15px;
            font-size: 1.5em;
        }
        h3 {
            color: #fff;
            margin-bottom: 10px;
            font-size: 1.2em;
        }
        .header {
            display: flex;
            justify-content: space-between;
            align-items: center;
            margin-bottom: 20px;
            padding-bottom: 15px;
            border-bottom: 2px solid #39CCCC;
            flex-wrap: wrap;
        }
        .logo {
            font-size: 1.5em;
            font-weight: bold;
            color: #39CCCC;
            flex: 1;
        }
        .header div {
            flex: 1;
            text-align: center;
            margin: 0 10px;
        }
        .footer {
            position: absolute;
            bottom: 10px;
            left: 20px;
            right: 20px;
            text-align: center;
            font-size: 0.8em;
            color: #ccc;
            border-top: 1px solid #ccc;
            padding-top: 5px;
            line-height: 1.2;
        }
        table {
            width: 100%;
            border-collapse: collapse;
            margin: 15px 0;
            background: rgba(255,255,255,0.1);
            font-size: 0.9em;
        }
        th, td {
            padding: 8px;
            text-align: left;
            border: 1px solid rgba(255,255,255,0.2);
        }
        th {
            background: rgba(0,0,0,0.2);
        }
        .kit-diagram, .chart-placeholder, .concept-diagram {
            text-align: center;
            margin: 15px 0;
            font-style: italic;
            color: #ccc;
            font-size: 0.9em;
        }
        nav {
            position: fixed;
            bottom: 10px;
            left: 50%;
            transform: translateX(-50%);
            z-index: 1000;
            display: flex;
            gap: 10px;
        }
        button {
            background: #39CCCC;
            color: white;
            border: none;
            padding: 12px 20px;
            cursor: pointer;
            border-radius: 5px;
            font-size: 1em;
            min-width: 80px;
            touch-action: manipulation;
        }
        button:hover {
            background: #0074D9;
        }
        button:disabled {
            background: #ccc;
            cursor: not-allowed;
        }
        ul {
            list-style-type: none;
            padding: 0;
        }
        li {
            margin: 8px 0;
            padding: 10px;
            background: rgba(255,255,255,0.1);
            border-radius: 5px;
            line-height: 1.4;
        }
        p {
            line-height: 1.5;
            margin-bottom: 10px;
            font-size: 1em;
        }
        /* Mobile-specific adjustments */
        @media (max-width: 768px) {
            .slide {
                padding: 15px;
            }
            h1, h2 {
                font-size: 1.3em;
            }
            h3 {
                font-size: 1.1em;
            }
            .header {
                flex-direction: column;
                text-align: center;
            }
            .header div {
                margin: 5px 0;
            }
            .logo {
                font-size: 1.3em;
            }
            table {
                font-size: 0.8em;
            }
            th, td {
                padding: 5px;
            }
            nav {
                bottom: 5px;
                flex-direction: column;
                width: 90%;
                left: 5%;
            }
            button {
                padding: 15px;
                font-size: 1.1em;
            }
            .footer {
                font-size: 0.7em;
                left: 15px;
                right: 15px;
            }
            ul li, p {
                font-size: 0.95em;
            }
        }
        @media (max-width: 480px) {
            .slide {
                padding: 10px;
            }
            h1, h2 {
                font-size: 1.2em;
            }
            table {
                display: block;
                overflow-x: auto;
                white-space: nowrap;
            }
        }
    </style>
</head>
<body>
    <div id="deck">
        <!-- Slide 1 -->
        <div class="slide active">
            <div class="header">
                <div class="logo">EVA Therapeutics, Inc.</div>
                <div>Venture Valuation Let's Interview Series</div>
                <img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAYAAAAfFcSJAAAADUlEQVR42mP8/5+hHgAHggJ/PchI7wAAAABJRU5ErkJggg==" alt="BIO TECH GATE" style="height: 40px; width: auto;">
            </div>
            <h2>Company Description</h2>
            <p style="text-align: center; font-size: 1.1em;">Focusing primarily on rescuing premature newborns with respiratory distress syndrome by the unprecedented enteral ventilation technology.</p>
            <div style="text-align: center; margin: 15px 0;">
                <span style="font-size: 3em; color: #39CCCC;">⭕ EVA</span>
            </div>
            <h3>Company Details</h3>
            <ul>
                <li>Founded: 2021</li>
                <li>No. of Employees: 8</li>
                <li>Type of Ownership: Private</li>
                <li>Stock Exchange: N/A</li>
                <li>Interviewee: OZAKI Hiromu, Co-Founder & CEO</li>
            </ul>
            <h3>Company Address</h3>
            <p>Doshokuji-ku, IF<br>530-0035 Osaka, Japan<br>https://evatx.jp/en</p>
            <h3>Introduction</h3>
            <p>As the company name self-describes, EVA (Enteral Ventilation via Anus) technology – for which Ig Nobel Prize (see EVA after Ventilation interview) was awarded – will offer a new paradigm to save patients in respiratory failure.</p>
            <p>Venture Valuation interviewed OZAKI Hiromu, Co-Founder & CEO.</p>
            <div class="footer">
                BIOTECHGATE by VENTURE VALUATION | Kasernenstrasse 11 | 8004 Zurich | Switzerland | T +41 (0) 43 321 86 50 | www.venturevaluation.com | www.biotechgate.com
            </div>
        </div>

        <!-- Slide 2 -->
        <div class="slide">
            <div class="header">
                <div class="logo">EVA Therapeutics, Inc.</div>
                <div>Venture Valuation Let's Interview Series</div>
                <img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAYAAAAfFcSJAAAADUlEQVR42mP8/5+hHgAHggJ/PchI7wAAAABJRU5ErkJggg==" alt="BIO TECH GATE" style="height: 40px; width: auto;">
            </div>
            <h2>Your First Project EVA101 for Prematurely Born Babies with Respiratory Distress Syndrome (RDS)</h2>
            <p>Your first project EVA101 for prematurely born babies with respiratory distress syndrome aims to be used in combination with pulmonary surfactant administration and standard respiratory support methods such as mechanical ventilation.</p>
            <p><strong>Ozaki:</strong> Alveoli collapse due to the high surface tension caused by the lack of pulmonary surfactants. This condition is called RDS.</p>
            <p>A study published in 2022¹ shows that by day 7 of age, 30% of premature newborns with RDS had died while the majority of those alive continued to need some form of respiratory support.</p>
            <p>Depending on RDS conditions of each infant, we estimate (chart below) it would help rescue around 86% of RDS infants in Japan, U.S., and five EU countries.</p>
            <table>
                <thead>
                    <tr><th>Neonatal RDS</th><th>Japan¹</th><th>Pre-Japan, U.S.</th><th>EVA-101</th><th>Target</th></tr>
                </thead>
                <tbody>
                    <tr><td><strong>Japan¹</strong></td><td>900K</td><td>90K</td><td>15K</td><td>10K</td></tr>
                    <tr><td><strong>U.S.²</strong></td><td>3.35M</td><td>350K</td><td>70K</td><td>46K</td></tr>
                    <tr><td><strong>EU³</strong></td><td>3.1M</td><td>296K</td><td>59K</td><td>39K</td></tr>
                    <tr><td><strong>Total 100K target patients</strong></td><td colspan="4"></td></tr>
                </tbody>
            </table>
            <p>¹ UNICEF, ² US-CDC, ³ EU-EC</p>
            <p>The EVA101 kit is designed for supplemental breathing through the rectum with oxygenated perfluorodecalin (PFD) liquid oxygen.</p>
            <p>The kit resembles PFD intravenous fluid. PFD, approved as artificial blood in the U.S. in 1989, is an inert material and no cellular absorption is expected. 30cc of PFD oxygenated liquid is applied each time, which enables internal breathing to last about four to six hours.</p>
            <div class="kit-diagram">
                [Placeholder for EVA-101 Kit Diagram: Medical Bag (PFD Perfluorodecalin), Infusion Materials, etc.]
            </div>
            <p>¹ Bulamba et al. BMC Pediatrics (2022):7.</p>
            <div class="footer">
                BIOTECHGATE by VENTURE VALUATION | Kasernenstrasse 11 | 8004 Zurich | Switzerland | T +41 (0) 43 321 86 50 | www.venturevaluation.com | www.biotechgate.com
            </div>
        </div>

        <!-- Slide 3 -->
        <div class="slide">
            <div class="header">
                <div class="logo">EVA Therapeutics, Inc.</div>
                <div>Venture Valuation Let's Interview Series</div>
                <img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAYAAAAfFcSJAAAADUlEQVR42mP8/5+hHgAHggJ/PchI7wAAAABJRU5ErkJggg==" alt="BIO TECH GATE" style="height: 40px; width: auto;">
            </div>
            <h2>The Body Expels the PFD After Around Four to Six Hours</h2>
            <p>The body expels the PFD after around four to six hours, then a fresh
